A Novel Encochleated Formulation Improves Atovaquone Activity in a Murine Model of Pneumocystis Pneumonia

Although atovaquone is effective in treating and preventing Pneumocystis pneumonia (PCP), its use is limited by nonlinear absorption and adverse events. The current study was undertaken to examine the activity of encochleated atovaquone (eATQ), a novel lipid-crystal nanoparticle formulation, in a mo...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Infect Dis
Main Authors: Cushion, Melanie T, Kumar, Parag, Lu, Ruying, Ashbaugh, Alan, Adeojo, Lilian W, Alfaro, Raul, Mannino, Raphael, Tramont, Edmund, Kovacs, Joseph A
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2020
Assuntos:
Major Articles and Brief Reports
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8280485/
https://ncbi.nlm.nih.gov/pubmed/33245345
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiaa731
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares